» Articles » PMID: 3531348

Effect of a Bacterial Extract on Cellular and Humoral Immune Responses in Humans

Overview
Date 1986 Jan 1
PMID 3531348
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A lyophilized extract from E. coli (OM-89) was studied for its immunomodulating properties and tolerance in humans. Its oral administration to healthy volunteers produced a selective increase in the active T-cell population without changes in other lymphocyte populations. A significant increase in the proliferative response to concanavalin A and phytohemagglutin was recorded, but not to pokeweed mitogen. No significant changes were observed in the serum levels of IgG, IgA and IgM. The clinical and biological tolerance of OM-89 was excellent, without any adverse side-effects or production of circulating immune complexes or of autoantibodies, while the in vitro investigation showed that it is not a mitogen. Thus in healthy subjects OM-89 seems to act mainly on the cell-mediated immune responses.

Citing Articles

Prospective Study in Children with Complicated Urinary Tract Infection Treated with Autologous Bacterial Lysates.

Hernandez-Chinas U, Chavez-Berrocal M, Ahumada-Cota R, Navarro-Ocana A, Rocha-Ramirez L, Perez-Del Mazo Y Microorganisms. 2021; 9(9).

PMID: 34576707 PMC: 8470462. DOI: 10.3390/microorganisms9091811.


A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.

Vischer T Ann Rheum Dis. 1988; 47(7):582-7.

PMID: 3041924 PMC: 1003574. DOI: 10.1136/ard.47.7.582.


Double-blind, placebo-controlled study of OM-8980 in rheumatoid arthritis.

Hauzeur J, Appelboom T Rheumatol Int. 1989; 9(2):71-6.

PMID: 2682980 DOI: 10.1007/BF00270248.


Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis.

Vischer T Clin Rheumatol. 1990; 9(3):356-61.

PMID: 2261735 DOI: 10.1007/BF02114396.


Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.

Conti P, Dempsey R, Reale M, Barbacane R, Panara M, Bongrazio M Immunology. 1991; 73(4):450-6.

PMID: 1833315 PMC: 1384575.